Furosemide — Drug Intelligence | 10 EU Trials

Filter these 10 trials by condition, phase, country and more.

Open in Search →

10 Registered trials

5 Recruiting

3 Completed trials

9 Sponsors

5 Countries

Phase III

Phase II

Phase IV

Phase III: 5 Phase II: 3 Phase IV: 2

Oversight events:

1 serious breach across 1 trial

View oversight register →

Indications tested

Chronic kidney disease 1

Sponsors using this IMP

Region Midtjylland 2 Bispebjerg Hospital 1 Centre Hospitalier Regional Universitaire De Tours 1 Centre Hospitalier Universitaire De Bordeaux 1 Centre Hospitalier Universitaire De Nantes 1 Fakultni Nemocnice Hradec Kralove 1 Fondazione Gimema Franco Mandelli Onlus 1 Fundacion Instituto De Investigacion Sanitaria Aragon 1 Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia 1

All trials

10 total

Medical therapy after shock wave lithotripsy Not authorised

2024-510792-38-00 Phase III 1 country Region Midtjylland
Medical therapy after shock wave lithotripsy Not authorised

2024-510792-38-01 Phase III 1 country Region Midtjylland
The role of intra-abdominal pressure and point of care ultrasound to guide decongestive therapy in Heart Failure (ABDOPOCUS-HF) Recruiting

2024-512901-22-00 Phase III 1 country Fundacion Instituto De Investigacion Sanitaria Aragon
The Impact of Inhaled Furosemide and Perorally Administered Levodropropizine on Dyspnea in Patients With Advanced Respiratory Diseases (INFU… Recruiting

2024-514672-41-00 Phase II 1 country Fakultni Nemocnice Hradec Kralove
VASODILATATION OR LOOP-DIURETICS FOR INITIAL TREATMENT OF PULMONARY CONGESTION DUE TO ACUTE HEART FAILURE – A RANDOMIZED PLACEBO-CONTROLLED … Recruiting

2022-500035-36-01 Phase IV 1 country Bispebjerg Hospital
THINK - intensification of blood pressure lowering Therapeutics based on diuretics versus usual management for uncontrolled Hypertension IN … Recruiting

2022-501494-39-00 Phase III 1 country Centre Hospitalier Regional Universitaire De Tours
Intra-arterial hepatic (IAH) infusion of radiolabelled somatostatin analogs in GEP-NET patients with dominant liver metastases Recruiting

2024-514785-39-00 Phase II 1 country Centre Hospitalier Universitaire De Bordeaux
Study to treat adult patients with Very High-Risk T-cell Acute Lymphoblastic Leukemia (ALL) with Daratumumab in addition to the National ALL… Ended

2024-511627-34-00 Phase II 1 country Fondazione Gimema Franco Mandelli Onlus
Withdrawal of Pharmacological Treatment in Patients Responding to Cardiac Resynchronization Therapy: (REMOVE) Ended

2023-504946-70-00 Phase IV 1 country Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia
Contribution of PET (positron emission tomography) scans for the preoperative assessment of symptomatic endometriosis lesions: TEP-ENDORUN Ended

2024-520423-88-00 Phase III 1 country Centre Hospitalier Universitaire De La Reunion

Showing 1–10 of 10 trials

← All drugs A–Z